Compare MNTK & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNTK | INGN |
|---|---|---|
| Founded | 1980 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.0M | 177.1M |
| IPO Year | 2020 | 2013 |
| Metric | MNTK | INGN |
|---|---|---|
| Price | $1.83 | $5.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | $1.80 | ★ $11.25 |
| AVG Volume (30 Days) | 183.0K | ★ 233.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | $176,382,000.00 | ★ $348,668,000.00 |
| Revenue This Year | $18.55 | $8.03 |
| Revenue Next Year | $12.68 | $7.76 |
| P/E Ratio | $146.00 | ★ N/A |
| Revenue Growth | 0.37 | ★ 3.86 |
| 52 Week Low | $1.07 | $5.34 |
| 52 Week High | $2.57 | $9.13 |
| Indicator | MNTK | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 60.02 | 34.86 |
| Support Level | $1.55 | $5.41 |
| Resistance Level | $1.97 | $6.84 |
| Average True Range (ATR) | 0.12 | 0.30 |
| MACD | 0.00 | -0.07 |
| Stochastic Oscillator | 70.97 | 14.95 |
Montauk Renewables Inc is a renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments namely Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.